Defeng Xu

2.0k total citations
108 papers, 1.6k citations indexed

About

Defeng Xu is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Defeng Xu has authored 108 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 26 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Defeng Xu's work include Nanoparticle-Based Drug Delivery (14 papers), Synthesis and Biological Evaluation (12 papers) and Prostate Cancer Treatment and Research (12 papers). Defeng Xu is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), Synthesis and Biological Evaluation (12 papers) and Prostate Cancer Treatment and Research (12 papers). Defeng Xu collaborates with scholars based in China, United States and Taiwan. Defeng Xu's co-authors include Chawnshang Chang, Hang Hu, Shuyuan Yeh, Shaoshun Li, Liang Liang, Hiroshi Miyamoto, Tzu‐Hua Lin, Lei Li, Huan Zhou and Wen Zhou and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Colloid and Interface Science.

In The Last Decade

Defeng Xu

101 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Defeng Xu China 22 648 378 243 185 183 108 1.6k
David Y. Léger France 25 748 1.2× 228 0.6× 170 0.7× 134 0.7× 316 1.7× 57 1.8k
Mehmet Varol Türkiye 16 847 1.3× 142 0.4× 163 0.7× 261 1.4× 181 1.0× 38 1.8k
Samia A. Shouman Egypt 26 650 1.0× 116 0.3× 399 1.6× 218 1.2× 189 1.0× 89 1.8k
Kriengsak Lirdprapamongkol Thailand 26 784 1.2× 120 0.3× 207 0.9× 194 1.0× 251 1.4× 70 1.9k
Antonio Pezone Italy 15 1.2k 1.9× 208 0.6× 204 0.8× 371 2.0× 368 2.0× 30 2.3k
Neelam Azad United States 26 1.3k 2.0× 305 0.8× 149 0.6× 392 2.1× 144 0.8× 54 2.4k
Małgorzata Kucińska Poland 21 512 0.8× 262 0.7× 190 0.8× 79 0.4× 270 1.5× 59 1.5k
Xuemei Huang China 24 795 1.2× 133 0.4× 110 0.5× 290 1.6× 173 0.9× 70 2.1k
Ana S. Fernandes Portugal 27 524 0.8× 92 0.2× 252 1.0× 144 0.8× 156 0.9× 101 1.8k
Cheng‐Hao Jin China 29 1.1k 1.7× 104 0.3× 162 0.7× 200 1.1× 69 0.4× 112 2.3k

Countries citing papers authored by Defeng Xu

Since Specialization
Citations

This map shows the geographic impact of Defeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defeng Xu more than expected).

Fields of papers citing papers by Defeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defeng Xu. The network helps show where Defeng Xu may publish in the future.

Co-authorship network of co-authors of Defeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Defeng Xu. A scholar is included among the top collaborators of Defeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defeng Xu. Defeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Bo, Yonghong Deng, Defeng Xu, & Xiubo Zhao. (2025). Dimethylcurcumin and Copper Sulfate-Loaded Silk Nanoparticles for Synergistic Therapy against Breast Cancer. ACS Biomaterials Science & Engineering. 11(3). 1539–1548. 3 indexed citations
2.
Hu, Hang, Ting Yuan, Xi Chen, et al.. (2024). Polyethylene glycol modified protamine-chlorin e6 conjugate nanoparticles for enhanced cancer photodynamic therapy. European Polymer Journal. 208. 112871–112871. 2 indexed citations
3.
Chen, Shuqiang, et al.. (2024). Design of Evodiamine–Glucose Conjugates with Improved In Vivo Antitumor Activity. Journal of Medicinal Chemistry. 67(9). 7373–7384. 6 indexed citations
4.
Cheng, Yi‐Lin, et al.. (2024). Synthesis and in vitro antitumor activity of galactosamine–docetaxel conjugates. Chemical Biology & Drug Design. 103(3). e14511–e14511. 1 indexed citations
5.
Liu, Shengping, et al.. (2024). Biotin‐new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution. Chemical Biology & Drug Design. 103(3). e14495–e14495. 2 indexed citations
6.
Sheng, Yang, Jiahui He, Sijie Wang, et al.. (2023). A signal amplification for Trp isomers electrochemical recognition based on PEDOT:PSS and CS/PAA multilayers. Talanta. 265. 124885–124885. 12 indexed citations
7.
Wang, Wei, et al.. (2023). Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead. Bioorganic & Medicinal Chemistry Letters. 92. 129393–129393. 7 indexed citations
8.
Tu, Jie, Tianbao Zhu, Qingwen Wang, et al.. (2023). Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections. Emerging Microbes & Infections. 12(1). 2208687–2208687. 4 indexed citations
9.
Sun, Yixin, Dandan Zhang, Yang Sheng, et al.. (2021). Supramolecular assembly induced chiral interface for electrochemical recognition of tryptophan enantiomers. Analytical Methods. 13(17). 2011–2020. 14 indexed citations
10.
Liu, Shengping, et al.. (2021). Hydroxyethyl starch-new indocyanine green conjugates for enhanced cancer photodynamic therapy. Carbohydrate Research. 508. 108416–108416. 9 indexed citations
11.
Hu, Hang, Xin Liu, Chen Xiao, et al.. (2021). Mesoporous polydopamine-based multifunctional nanoparticles for enhanced cancer phototherapy. Journal of Colloid and Interface Science. 612. 246–260. 46 indexed citations
12.
Zhu, Tianbao, Xi Chen, Jie Tu, et al.. (2021). Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections. European Journal of Medicinal Chemistry. 221. 113524–113524. 34 indexed citations
13.
Guan, Jing, et al.. (2020). Facile and green synthesis of 4,6-dimethoxy-2-methylsulfonylpyrimidine using chloromethane as methylating agent. Journal of the Chinese Institute of Engineers. 44(1). 72–76. 1 indexed citations
14.
Jiang, Bo, Yong Luo, Jianyong Zou, et al.. (2020). Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Chou, Fu-Ju, Keliang Wang, Rachel Yang, et al.. (2017). Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. Cancer Letters. 417. 182–191. 38 indexed citations
16.
Hsu, Iawen, Defeng Xu, Hiroshi Miyamoto, et al.. (2013). Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor. American Journal Of Pathology. 182(5). 1811–1820. 99 indexed citations
17.
Huang, Chiung‐Kuei, Soo Ok Lee, Defeng Xu, et al.. (2013). Determination of androgen receptor degradation enhancer ASC-J9® in mouse sera and organs with liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 88. 117–122. 21 indexed citations
18.
Yamashita, Shinichi, Kuo-Pao Lai, Kun‐Lung Chuang, et al.. (2012). ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors. Neoplasia. 14(1). 74–IN12. 120 indexed citations
19.
Xu, Defeng, Xiaojuan Guo, Zhaohui Xu, & Shaoshun Li. (2006). A Novel Total Synthesis of (±) Shikonin. Chinese Chemical Letters. 17(7). 871–873. 4 indexed citations
20.
Wang, Jie, Jianjun Zou, Yong Gao, et al.. (2005). Double-blinded, Controlled, Randomized Study of Dihydrocodeine Tartrate vs Codeine Phosphate in Treating Cancer Pain. The Chinese-German Journal of Clinical Oncology. 4(2). 108–111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Y. Léger Breakdown of academic impact, for papers by Mehmet Varol Breakdown of academic impact, for papers by Samia A. Shouman Breakdown of academic impact, for papers by Kriengsak Lirdprapamongkol Breakdown of academic impact, for papers by Antonio Pezone Breakdown of academic impact, for papers by Neelam Azad Breakdown of academic impact, for papers by Małgorzata Kucińska Breakdown of academic impact, for papers by Xuemei Huang Breakdown of academic impact, for papers by Ana S. Fernandes Breakdown of academic impact, for papers by Cheng‐Hao Jin
Rankless by CCL
2026